Abstract
In this chapter, we present the main concepts to approach a patient with a psychodermatologic disorder. We present general topics to conduct a clinical history in psychodermatology as well as to perform a brief assessment of psychopathology and quality of life, that could be done in the context of general medicine. Most of these patients are not firstly seen by a specialist in psychodermatology. General education in this domain allows to identify relevant psychosocial aspects in dermatology, to address potentially easier clinical cases and to quickly refer those with risk criteria.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lagerros YT. Physical activity--the more we measure, the more we know how to measure. Eur J Epidemiol. 2009;24(3):119–22.
Sanclemente G, Burgos C, Nova J, Hernández F, González C, Reyes MI, Córdoba N, Arévalo Á, Meléndez E, Colmenares J, Ariza S, Hernández G, Asociación Colombiana de Dermatología y Cirugía Dermatológica (Asocolderma). The impact of skin diseases on quality of life: a multicenter study. Actas Dermosifiliogr. 2017;108(39):244–52.
Chren MM. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin. 2012;30(2):231–6, xiii.
Mattei PL, Corey KC, Kimball AB. Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies. J Eur Acad Dermatol Venereol. 2014;28(3):333–7.
Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001;137(3):280–4.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–6.
Bolognia JL, Schaffer JV, Duncan KO, Ko CJ. Pruritus and dysesthesia. In: Bolognia JL, Schaffer JV, Duncan KO, Ko CJ, editors. Dermatology essentials. 3rd ed. Oxford: Saunders/Elsevier; 2014. p. 39–49.
Ferreira BR, Pio-Abreu JL, Reis JP, Figueiredo A. First psychodermatologic clinic in a Portuguese Department of Dermatology. J Eur Acad Dermatol Venereol. 2019;33(3):e119–20.
Reddy MS. Insight and psychosis. Indian J Psychol Med. 2015;37(3):257–60.
Katsoulis K, Rutledge KJ, Jafferany M. Delusional infestation: a prototype of psychodermatological disease. Int J Dermatol. 2019.
Altaf K, Mohandas P, Marshall C, Taylor R, Bewley A. Managing patients with delusional infestations in an integrated psychodermatology clinic is much more cost-effective than a general dermatology or primary care setting. Br J Dermatol. 2017;177(2):544–5.
Phillips KA, Dufresne RG Jr. Body dysmorphic disorder: a guide for primary care physicians. Prim Care. 2002;29(1):99–111, vii.
Mohandas P, Bewley A, Taylor R. Dermatitis artefacta and artefactual skin disease: the need for a psychodermatology multidisciplinary team to treat a difficult condition. Br J Dermatol. 2013;169(3):600–6.
Jafferany M, Kobusiewicz A, Ferreira BR, Garan S, Havryliuk O. Factitious disorders in children: clinical and therapeutic consideration. Dermatol Venereol. 2019;2(84):8–14.
Bagby RM, Taylor GJ, Parker JD. The twenty-item Toronto alexithymia scale--II. convergent, discriminant, and concurrent validity. J Psychosom Res. 1994;38(1):33–40.
Trivedi D. Cochrane review summary: Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Prim Health Care Res Dev. 2017;18(6):527–8.
Abramowitz JS, Deacon BJ, Olatunji BO, Wheaton MG, Berman NC, Losardo D, Timpano KR, McGrath PB, Riemann BC, Adams T, Björgvinsson T, Storch EA, Hale LR. Assessment of obsessive-compulsive symptom dimensions: development and evaluation of the Dimensional Obsessive-Compulsive Scale. Psychol Assess. 2010;22(1):180–98.
Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64(2):258–66.
Williams N. The CAGE questionnaire. Occup Med (Lond). 2014;64(6):473–4.
Finlay AY. Quality of life assessments in dermatology. Semin Cutan Med Surg. 1998;17(4):291–6.
Lewis-Jones MS, Finlay AY, Dykes PJ. The infants’ dermatitis quality of life. Br J Dermatol. 2001;144:104–10.
Wilhelm S, Greenberg JL, Rosenfield E, Kasarskis I, Blashill AJ. The Body Dysmorphic Disorder Symptom Scale: development and preliminary validation of a self-report scale of symptom specific dysfunction. Body Image. 2016;17:82–7.
Chiricozzi A, Bettoli V, De Pità O, Dini V, Fabbrocini G, Monfrecola G, Musumeci ML, Parodi A, Sampogna F, Pennella A, Buzzulini F, Gualberti G, di Luzio Paparatti U, Atzori L. HIDRAdisk: an innovative visual tool to assess the burden of hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2019;33(1):e24–6.
Finlay AY, Khan GK, Luscombe DK, Salek MS. Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol. 1990;123(6):751–6.
Rhee JS, Matthews BA, Neuburg M, Logan BR, Burzynski M, Nattinger AB. The skin cancer index: clinical responsiveness and predictors of quality of life. Laryngoscope. 2007;117(3):399–405.
Keuthen NJ, Wilhelm S, Deckersbach T, Engelhard IM, Forker AE, Baer L, Jenike MA. The Skin Picking Scale: scale construction and psychometric analyses. J Psychosom Res. 2001;50(6):337–41.
Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol. 1995;132(6):942–9.
Vázquez-Herrera NE, Sharma D, Aleid NM, Tosti A. Scap itch: a systematic review. Skin Appendage Disord. 2018;4(3):187–99.
Goyal N, Shenoi S, Prabhu SS, Sreejayan K, Munoli R, Rai S. Psychodermatology liaison clinic in India: a working model. Trop Dr. 2018;48(1):7–11.
Muralidharan V, Zahedi D, Kaur B, Goulding JMR. Diagnosis and management of psychodermatological problems: confidence levels among dermatologists and psychiatrists. Clin Exp Dermatol. 2019.
Elpern DJ. Medically unexplained dermatologic symptoms still a problem. J Eur Acad Dermatol Venereol. 2018;32(12):e449.
Elpern DJ. Digging for the deeper diagnoses in dermatology. Perm J. 2019;24:19.090.
Connor CJ. Management of the psychological comorbidities of dermatological conditions: practitioners’ guidelines. Clin Cosmet Investig Dermatol. 2017;10:117–32.
Roche L, Switzer V, Ramsay B. A retrospective case series of referrals to our psychodermatology clinic 2009-2016. J Eur Acad Dermatol Venereol. 2018;32(7):e278–9.
Kearley KE, Freeman GK, Heath A. An exploration of the value of the personal doctor-patient relationship in general practice. Br J Gen Pract. 2001;51(470):712–8.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2020 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Roque Ferreira, B., Jafferany, M., Patel, A. (2020). Screening Questionnaires, Scales and Approach to Patients with Psychodermatologic Disorders. In: The Essentials of Psychodermatology. Springer, Cham. https://doi.org/10.1007/978-3-030-45582-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-45582-8_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-45581-1
Online ISBN: 978-3-030-45582-8
eBook Packages: MedicineMedicine (R0)